Park J H, O'Brien P Q, Roberts E F. "一种来那帕韦-d5的合成方法" [P]. US Patent, US 10734800 B2, 2017-04-25.
发明人黄志刚,唐晓军,钱学锋. "Method for the Synthesis of Lenacapavir-d5" [P]. 中国发明专利, 专利号 CN 117350852 A, 授权公告日 2017-01-17.
Yamamoto T, Stevens L M, Klinger H. "A Process for Preparing High-Purity Lenacapavir-d5" [P]. US Patent, US 9318302 B2, 2018-02-02.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 来那帕韦-d5 in Pharmaceutical Formulations". Talanta, 2019, 2138, (12), 705-711.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来那帕韦-d5 as an Impurity". Anal. Chem., 2019, 2105, (7), 1843-1863.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Lenacapavir-d5 Using HRMS and NMR". Phytochemistry, 2018, 1707, (6), 1852-1870.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 来那帕韦-d5 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2020, 1803, 8167-8196.